BTS
BIVV

BB&T Securities’s Bioverativ Inc. Common Stock BIVV Stock Holding History

BB&T Securities’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-6,747
Closed -$363K – 1588
2017
Q4 		$363K Buy
+6,747
New +$369K ﹤0.01% 1114
2017
Q3 		– Sell
-5,035
Closed -$302K – 1491
2017
Q2 		$302K Buy
+5,035
New +$287K ﹤0.01% 1143

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

BB&T Securities's BIVV Position: Q1 2018 in Review

BB&T Securities sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 6,747 shares — an estimated $363K sold.

BB&T Securities first reported a position in BIVV in Q2 2017 and held it in 2 quarters. The position peaked at $363K in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • BB&T Securities reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • BB&T Securities sold 6,747 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $363K.
  • BB&T Securities first reported a position in Bioverativ Inc. Common Stock in Q2 2017 and held it in 2 quarters.
  • BB&T Securities's Bioverativ Inc. Common Stock position peaked at $363K in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on BB&T Securities's 13F filing for Q1 2018, filed 14 May 2018.